Each NEOLIPYDRA FORTE tablet contains 240 milligrams of highly concentrated, one percent (1%) extract of the Monascus purpureus yeast metabolites.
The other ingredients of the tablet are calcium hydrogen phosphate, maize starch, povidone, copovidone, magnesium stearate.
1. WHAT DO NOT LEAVE FORTE:
NEOLIPYDRA FORTE is a biotechnological product obtained from the fermentation of Monascus purpureus on wet rice. Biologically active substances in NEOLIPYDRA FORTE are: 14 different monacolins - inhibitors of HMG-CoA reductase, sterols, isoflavones, mono- and polyunsaturated fatty acids, saturated fatty acids, pigments.
2. HOW DOES NEILIPYDRA FORT WORK
The main biologically active substances in NEOLIPYDRA FORTE are the monocolines. They suppress the formation of cholesterol in the liver. The lowering of cholesterol is partly due to the action of other biologically active substances.
3. WHAT WE HAVE TO KNOW ABOUT CHOLESTEROL?
Cholesterol is a type of fat in the blood. Blood cholesterol comes from two sources. Most cholesterol is produced in the liver. The other source of cholesterol is food. The total cholesterol in the body consists of LDL and HDL cholesterol.
LDL cholesterol is called "bad" cholesterol, because it can be deposited on the walls of the blood vessels and form atherosclerotic plaques, as the plaque grows and narrows the blood vessels, especially the arteries, which makes it difficult or completely block blood supply to vital organs like heart, brain, etc. High LDL cholesterol is the main cause of cardiovascular disease, heart attack and stroke.
HDL cholesterol is called "good" cholesterol because it prevents "bad" cholesterol from being deposited in the walls of the blood vessels.
4. WHO SHOULD NOT RECEIVE NON-LIPID FORTE
It is not recommended to take NEOLIPYDRA FORTE in the following cases:
• Hypersensitivity to any of the ingredients of the tablet, as well as known hypersensitivity to yeast. The most common symptoms of an allergic reaction include rash, itching, swelling of the lips and face, shortness of breath. Ask your doctor if you experience any of these symptoms.
• Pregnancy, pregnancy planning or breastfeeding.
5. WHAT YOU MUST SELL TO YOUR DOCTOR BEFORE TAKING NON-LIPID FORTE
Tell your doctor if:
• You are taking any of the following medicines:
♦ Ciclosporin
♦ Nefazodone
♦ Antifungal agents: itraconazole, ketoconazole
♦ Fibrates: gemfibrozil, bezafibrate, fenofibrate
♦ Antibiotics: erythromycin, clarithromycin
♦ Coumarin anticoagulants
♦ HIV protease inhibitors
♦ Antiarrhythmic agents: amiodarone, verapamil, propranolol
♦ Digoxin
♦ Hypoglycaemic agents: glipizide, chlorpropamide
♦ Large amounts of grapefruit juice (> 1.14 liters per day)
• You suffer from a serious infection
• You have a transplanted organ
• You have had a surgical operation soon
• You use large quantities of alcohol
6. WHO SHOULD RECEIVE NON-LIPID FORTE
NEOLIPYDRA FORTE is suitable for use in patients with elevated cholesterol levels without other concomitant illness as well as in patients with coronary artery disease to reduce the risk of myocardial infarction, unstable angina pectoris, and coronary vascular revascularization procedures.
7. WHAT ARE THE SIDE EFFECTS OF NON-LIPID FORTE?
There are no side effects from the use of the preparation at therapeutic doses. In case of overdose, it is possible to see transient gastrointestinal symptoms such as refluxing, dry mouth, stomach swelling, gas and vomiting. When the dose is normalized, these symptoms quickly disappear. NEOLIPYDRA FORTE is generally well tolerated, undesirable side effects are usually mild and transient.
8. HOW TO TAKE NIOLIPYDRA FORTE
The dose of NEOLIPYDRA FORTE is determined by body weight and severity of the condition.
Usually NEOLIPYDRA FORTE is taken twice a day with 1 tablet of 240 mg. or 480 mg. daily. The evaluation of the efficacy of NEOLIPYDRA FORTE should be made no earlier than 8 weeks after the start of the intake.
If the total cholesterol and LDL-cholesterol levels are not satisfactorily reduced and in patients with high body weight, it is recommended to increase the daily dose by one tablet. The additional dose of 1 tablet is given with evening intake, ie. morning 1 tablet and evening 2 tablets or total daily intake of 3 tablets (720 mg).
If you need to further increase your daily dose to 4 tablets (960 mg / day), take 2 tablets in the morning and 2 tablets in the evening. The daily dose should not exceed 4 tablets or 960 mg.
9. STORAGE
Keep the preparation at room temperature in places out of reach of children.
Store Neolipidra FORTE in the original package. Do not use the product after its expiration or if the integrity of its packaging is impaired.
Packing: 30 tablets.